Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit
Genomics software firm PierianDx raises $27 million

Genomics software firm PierianDx raises $27 million

  • 0
{{featured_button_text}}
Genome Institute at Washington University

Karyn Meltz Steinberg, an instructor of genomics and bioinformatics at the Genome Institute at Washington University, looks for genomic variants from data generated by Illumina sequencing machines on Thursday, April 23, 2015. Photo by Cristina Fletes-Boutte, cfletes-boutte@post-dispatch.com

PierianDx, a genomics software firm that was spun out of Washington University in 2014, has raised $27 million in capital to support its growth.

The St. Louis firm, based in the Central West End, offers software for precision medicine, in which genetic analysis is used to provide targeted therapies. PierianDx's founder and chairman, Rakesh Nagarajan, is also an adjunct associate professor of pathology and immunology at Washington University.

Chief Executive Michael Sanderson said in a statement that the funding would accelerate PierianDx's commercial expansion in the U.S. and globally. 

The Series B venture capital round was led by ATW Partners of New York and SJF Ventures of Durham, North Carolina. PierianDx had previously raised a total of $17 million, according to Crunchbase, including a $9.3 million Series A round in 2016.

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Get up-to-the-minute news sent straight to your device.

Topics

Trending

Blues News

Breaking News

Cardinals News

Daily 6

National Breaking News

Sports